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1. Introduction  
The direct cell-to-cell communication is performed by gap junctions (GJ) composed of 
connexin (Cx), a large protein family with a number of subtypes. GJ channels allow the 
propagation of electrical impulse and the transfer of small molecules (up to 1,000 to 1,500 
Da) between two neighbouring cells (Figure 1). And it has also become clear that different 
combination of Cxs are expressed in different tissues with temporal specificity during 
development or tissue differentiation (Paul, 1995). By such a rigid regulation, Cxs contribute 
to maintain cellular homeostasis in many organs. On the contrary, expression levels of Cx 
proteins are often decreased in many cancers, and restoring their levels has been shown to 
have antitumor effects. In this concept, there is a possibility to establish a new cancer 
therapy based on tumor-suppressive functions of Cxs for refractory cancers, such as 
mesothelioma.  
Malignant mesothelioma is an aggressive and devastating malignancy of the pleura and 
peritoneum. Although it has been the subject of intense clinical and scientific interest, the 
case-fatality rate for mesothelioma remains high, and conventional treatments remain 
inadequate. Systemic chemotherapy is important since it is a whole-body treatment and is 
useful for patients who cannot be treated with surgery. Cisplatin (CDDP) has been used in 
clinical mesothelioma therapy, and its chemotherapeutic effect as a single agent (Ryan et al, 
1998) as well as in combination with other drugs such as gemcitabine has been examined 
(Byrne et al, 1999; van Haarst et al, 2002; Vogelzang et al, 2003).  
In this chapter, we introduce the tumor-suppressive effect of Cx gene against mesothelioma, 
especially with regard to chemotherapeutical sensitivity. 
2. The possible involvement of Cx43 in mesothelioma 
GJ channels are formed by two hemichannels provided by either of neighboring cells. Each 
hemichannel is a hexameric pore structure made from 6 protein subunits, Cxs. Cx is a 
protein with four transmembrane spanning domain, two extracellular and one intracellular 
loop, and N- and C-terminal at the intracellular side (Kumar & Gilula, 1996). The various Cx 
isoforms differ with regard to their molecular weight due to different length of their C-
terminal region. There are 21 Cx morecules which were identified in human so far. With 
regard to mesothelioma, dysfunction of gap junctional intercellular communication (GJIC) 
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has been observed in several malignant mesotheliomas cells or tissues (Linnainmaa et al, 
1993), and among the many Cx proteins, Cx43 is prominently expressed in nontumorigenic 
mesothelial tissues (Pelin et al, 1994). Besides that, we found that Cx43 expression was very 
low in human malignant mesothelioma cells (Figure 2A, left). We also examined GJIC ability 
using fluorescent dye, Lucifer yellow. The molecular size of Lucifer yellow is small enough 
to pass through GJ, so the spreading distance of this dye tells the GJIC ability (el-Fouly, 
1987). By using this method, it became clear that GJIC function was almot dysfunctional in 
mesothelioma cells (Figure 2B, above). Taken together, it seems that Cx43 has an important 
role in the parental mesothelial cells and upregulation of Cx43 could reduce malignancy of 
mesothelioma.  
 
Fig. 1. The structure of connexin (Cx) protein as a component of gap junction (GJ), hemi-
channel, and as a membrane protein. 
Gap junctions (GJ) provide a pathway for communication between neighboring cells. GJ are 
organized in plaques at the cell membrane surface and arise from 2 connexons 
(hemichannels) from neighboring cells. Connexons are composed of 6 connexin (Cx) 
proteins. GJ channels can be permeable to only small molecules (around 1,000 Da), which 
contribute to keep cellular homeostasis. It has been suggested that the down-regulation of 
Cx genes is associated with the development of cancers. Besides GJ, hemichannels provide a 
pathway for the extracellular release of essential homeostasis regulators, like ATP. 
Moreover, carboxy-terminal (C-tail) of Cx protein has a possibility to modulate gene 
expression via binding proteins, which can be also modulated by other proteins. Ex) C-tail 
of Cx43 includes target sites of Src phosphorylation (Giepmans, 2004)  
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3. Effect of Cx43 mono-therapy 
Recent studies have suggested that not all Cx genes could exert a tumor-suppressive effect 
on a given tumor but rather than that there seems to be Cx-cell type compatibility for this 
effect (Yano et al, 2006, as cited in Mesnil et al, 1995). That means Cx can exert growth 
control only in tissue or cell type in which the particular Cx is naturally expressed. Indeed, 
overexpression of Cx43 in MDA-MB-231 cells results in downregulation of fibroblast growth 
factor receptor (FGFR)-3, a member of the FGFR family consisting of potent angiogenic 
factors, which contribute tumor growth and invasion (Qin et al, 2002). According to this 
concept, we previously investigated the tumor suppressive role of Cx32 in renal cell 
carcinoma, in which Cx32 expression is downregulated (Yano et al, 2003), using a forced 
expression clone of Cx32. As expected, we found that Cx32 acts as a tumor suppressor gene 
in renal carcinoma cells (Fujimoto et al, 2005). 
Here, in order to estimate if Cx43 could suppress malignant phenotype of mesothelioma 
cells, we arranged a Cx43 transfected clone (Cx43 transfectant) and only mock-tranfected 
clone (mock), as a control. Naive cell characteristics were compared between Cx43 
transfectant and mock. As expected, when attached condition, the growth was significantly 
inhibited by Cx43 (Figure 2C-i). Next, to examine anchorage-independent growth, the  
 
Fig. 2. The naïve role of Cx43 on human mesothelioma cells.  
A) and B) show characteristics of mesothelioma cells. Cx43 expression A) and GJIC activity 
B) in human mesothelioma cells, parental H28 (‘Parental’), mock-transfectant (‘Mock+’), and 
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Cx43-transfectant (‘Cx43+’) are shown. a), c), and e); phase-contrast image, b), d), and f); dye 
transfer of Lucifer yellow from the scrape lines. C) indicates effect of Cx43 on cell growth i) 
when attached condition or ii) when non-attached (anchorage independent) condition . 
Scale shows cell number (i) or colony number (ii). Cell growth was significantly inhibited 
when attached condition in Cx43-transfectant compared to parental (###P <0.001) or mock 
cells (***P <0.001).  
number of cell colonies formed in three-dimentional agarose gels were countted. This time, 
however, there was almost no difference between cells (Figure 2C-ii). This finding indicates 
that the proliferation ability of a single cell, which is needed for survival in a nonmatrix 
environment, is almost the same between different cell types used in this study. There was 
also no difference in migration ability (data not shown). One possible reason why 
restoration of Cx43 could not inhibit cell growth enough is disruption of Cx protein 
traffiking systems. To put it plainly, Cx protein can not be transported from nucleus to 
cytoplasmic membrane. Under abnormal localization of Cx protein traffiking, Cxs could not 
exert tumor suppressive effect neither in GJIC dependent or independent manner, although 
the reason why it happens is unclear (Trosko & Ruch, 2002). Above all, it is suggested that 
restoring Cx43 expression alone cannot prevent tumor expansion or metastasis competely. 
4. Combination effect of Cx43 and CDDP 
As mentioned, mesothelioma is very refractory cancer. Radiotherapy and chemotherapeutic 
agents are ineffective in many cases despite surgery resection is possible only in case the 
tumor is very early stage or it is very limited focus. Recently, pemetrexed, a novel 
multitargeted antifolate, has shown modest activity when used as a single agent and in 
combination with CDDP in mesothelioma patients. However, although pemetrexed is 
promising, it has yet to be standardized because of the severity of its side effects and the 
presence of nonresponders. On the other hand, there are several reports of enhancement 
efficacy of conventional chemotherapy on cancers by Cxs, which are called bystander effect. 
Actually, we have reported that cytotoxic effects of conventional chemotherapeutic agents 
on cancer cells are potentiated by Cx32 in lung cancer (Sato et al, 2007a) and renal cell 
carcinoma (Sato et al, 2007b). Moreover, Cx43-mediated GJIC has been reported as a major 
mechanism for the transfer of ganciclovir (nucleoside analogue) to neighboring cells 
(Elshami et al, 1996). Therefore, we examined the combined effect of Cx43 and a 
chemotherapeutic agent, CDDP.  
4.1 Cx43-dependent induction of the CDDP cytotoxicity 
As expected, it was confirmed that mesothelioma cells were resistant to CDDP; 
approximately 80% of cells survived after exposure to high concentrations of CDDP 
(Fighure 3A). In contrast, Cx43 reduced cell viability and only approximately half of the 
mesothelioma cells or mock cells survived after being treated with 50 μM of CDDP (Figure 
3A). To confirm the contribution of Cx43 to the enhancement of CDDP-induced damage, we 
knocked down Cx43 expression by using specific siRNA. As a result, sensitivity to CDDP 
was attenuated by knockdown of Cx43 (Figure 3B); therefore the involvement of Cx43 in 
CDDP-induced damage was confirmed. 
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Fig. 3. Effect of Cx43 on CDDP-induced cytotoxicity.  
A) shows CDDP cytotoxicic effect on human mesothelioma cells, parental H28 (‘Parental’), 
mock-transfectant (‘Mock+’), and Cx43-transfectant (‘Cx43+’). The cell viability after CDDP 
treatment was significantly decreased in Cx43-transfectant compared with parental cells 
(###P <0.001) or mock cells (***P <0.001). B) shows effect of Cx43-knockdown on Cx43-
transfectant cell growth after CDDP treatment. The cell viability in cells co-treated with 
siRNA and CDDP (‘siRNA+CDDP’) recovered to control level. ###, ***, and ┼┼┼ P <0.001; 
Significant differences compared with only treated with CDDP group (‘CDDP’). 
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4.2 Molecular mechanism of Cx43 which contributes to the CDDP cytotoxicity  
Here, it is confirmed that Cx43 significantly enhances CDDP growth inhibiting effect and 
apoptosis might be induced, that is, Cx43 upregulates the sensitivity to CDDP in 
mesothelioma cells. Then considering the involvement of GJIC, molecular mecahnism of this 
phenomenon was investigated via cell cycle distribution, apoptotic factors, and Src which 
could interact with Cx43 protein. 
4.2.1 Gap junction dependent manner 
To determine the influence of GJIC on CDDP-induced cytotoxicity, we usede a GJ blocker, 
18β-glycyrrhetinic acid (GA). After 4 h of culturing with GA, CDDP treatment followed, 
then cell viability was determined using WST-1 Reagent. As a result of Lucifer yellow dye 
spreading assay, GJIC inhibiting effect by GA was observed in Cx43-transfectant (Figure 
4A). However, such inhibition of GJIC had almost no effect on cell viability detected by 
WST-1 assay (Figure 4B). Thus, inhibition of GJ-dependent function with a specific inhibitor 
did not abrogate CDDP-induced cytotoxicity. These results suggest that Cx43-mediated 
enhancement of cytotoxicity might be independent of GJ function.  
On the other hand, there are several reports concerning the relation of GJIC and CDDP 
cytotoxicity. One of the previous reports suggests a posibility that CDDP could affect GJIC, 
it might be regulated by MAP kinase-dependent phosphorylation of specific sites of Cx43 
(Procházka et al, 2007). Because it is known that CDDP toxicity is modulated by a MAP 
kinase pathway besides the established mechanisms (Park et al, 2002; Woessmann et al, 
2002) and that Cxs are regulated by multiple mechanisms, including MAP kinase dependent 
phosphorylation (Jo et al, 2005; Lampe & Lau, 2004; Wang et al, 2000). Procházka et al 
showed a new platinum complex, LA-12, had strong GJIC inhibiting effect (Procházka et al, 
2007). They also found the inhibitory effect of GJIC was induced by hyperphosphorylation 
of Cx43 protein which decrease the localization of cell membrane, which correlated with 
activation of MAP kinase pathway proteins. On the other hand CDDP exerted only a low 
effect on GJIC though the drug caused activation of MAP kinase protein (Procházka et al, 
2007). Another report which supports Procházka et al showed that Cx43 level was elevated 
in CDDP- resistant cell line (Li et al, 2007). Li et al indicated the conflicting reports in which 
the role of Cxs in cell survival were different; in case GJ component protein, they have been 
implicated the bystander effect, but Cx43 protein itself has also been shown to be important 
in cell survival, although this function is poor characterized. They also suggested that 
although the selection of CDDP resistance might have favored cells that expressed high level 
of Cx43, continued expression of this gene might decrease drug resistance by promoting a 
bystander effect, and finally concluded that Cx43 played a role in drug sensitivity in any 
case (Li et al, 2007). Meanwhile other reports showed that compounds like CDDP 
suppressed intercellular communication (Jo et al, 2005; Wang et al, 2000).  
Taken together, it is still unclear if GJIC involves to the enhanced effect of CDDP by Cx43. 
Further investigation of this concern which magnify more elaborate apoptotic pathway field 
will be needed.  
4.2.2 Gap junction independent manner 
In this section, several factors which probably concern the mecahnism of Cx43 induced 
cytotoxicity of CDDP are suggested irrespective of GJIC. 
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Fig. 4. Effect of GJ blockade on CDDP-induced cytotoxicity. 
A); GJ inhibitor (GA) downregulated GJIC in Cx43-transfectant. ‘GA+’; cells treated with GA 
for 4 h, ‘GA-’; cells treated with only 0.1%dimethylsulfoxide (DMSO, vehicle for GA). a) and 
c); phase-contrast image, b) and d); dye transfer of Lucifer yellow from the scraped lines. B); 
Cell viability after CDDP treatment in Cx43-transfectant was detected by WST-1 assay. 
Downregulating effect of CDDP did not recover by pre-treamtent of GA 4 h. ‘Control’; cells 
treated with only 0.1% DMSO (vehicle for CDDP), ‘GA’; cells pre-treated with GA for 4 h 
followed 0.1% DMSO treatment for 48 h, ‘CDDP’; cells treated with only CDDP for 48 h, and 
‘GA+CDDP’; cells pre-treated with GA for 4 h followed CDDP treatment for 48 h. ###P < 
0.001; Significant difference between ‘Control’ and ‘CDDP’, ***P <0.001; significant 
difference between ‘GA’ and ‘CDDP’.  
4.2.2.1 Regulation of cell cycle distribution by Cx43 
We also checked cell cycle distribution after exposure to CDDP in mesothelioma cells. In 
both parental mesothelioma cell or Cx43-transfectant, an increase in the G1-phase 
population was observed after CDDP treatment for more than 24 h (Figure 5A). On the other 
hand, the S-phase population increased by Cx43. And we also compared the sub-G1 peak 
between cells. A higher sub-G1 population was induced by Cx43, indicating upregulation of 
apoptosis. It has been reported that DNA modification by CDDP activates the G1 checkpoint 
(Un, 2007). This checkpoint exists to halt cell cycle progression in the event of DNA damage 
to allow time for repair before initiating DNA replication (Wang et al, 2001). However, even 
those cells which retain G1 checkpoint eventually die when they are exposed to persistent 
treatment. Therefore it is suggested that G1 arrest represents a critical determinant of CDDP 
cytotoxicity (Un, 2007). In our study, G1 arrest was observed in both parental mesothelioma 
cells and Cx43-transfectant (Sato et al, 2009). Therefore, the G1 checkpoint does not appear to 
have broken down in these cells. As expected, an obvious induction of apoptosis was 
observed by Cx43. This observation might be explained by the additive effect of Cx43 on cell 
cycle distribution, inducing S-phase arrest. Thus, two surveillance mechanisms possibly 
work independently in the G1 and S checkpoints, making it easy to suppress progression of 
the cell cycle and induce apoptosis in mesothelioma. 
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Fig. 5. Effect on cell cycle distribution by Cx43.  
A) shows changes in cell cycle distribution in parental mesothelioma cells (‘Parental’) and in 
Cx43-transfectant cells (‘Cx43+’) after 25 µM of CDDP stimulation. Cells were treated with 
CDDP for the indicated periods, and 20,000 cells of each group were analyzed by flow 
cytometry. Control cells were treated with only 0.1% dimethylsulfoxide (vehicle for CDDP). 
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S-phase arrest was observed in Cx43-transfctant. B) shows effect on the induction of sub-G1 
population (estimated apoptosis) of mesothelioma cells 48 h CDDP treatment. Strong 
induction of sub-G1 population was observed in Cx43 transfectant.  
4.2.2.2 Effect of Cx43 on apoptotic factors 
Proteins of the Bcl-2 family play an important role in the regulation of programmed  
cell death. Overexpression of Bcl-2, an anti-apoptotic factor, is associated with resistance 
to various cytotoxic agents, while the Bax protein is a pro-apoptotic member of the  
Bcl-2 family. In our study, no differences were noted in the levels of Bcl-2 among parental 
mesothelioma cells, mock, and Cx43-transfectant (Sato et al, 2009). On the other hand,  
Bax expression was strongly upregulated in Cx43-transfectant compared to the other  
two. Thus, the Bcl-2 family balance appeared to lean toward enhancing apoptosis by 
Cx43.  
The Bcl-2 family proteins are invovlved in most of apoptosis pathway, so they are 
attractive target for cancer therapy (Kim et al, 2004). A previous study reported little or no 
expression of Bcl-2 but high expression of Bcl-xL and a pro-apoptotic protein, Bax, in 
mesothelioma histological sections and cells (Soini et al, 1999). Our results showed a 
different trend: Bcl-2 but not Bcl-xL was detected (data not shown). However, the 
important finding was the balance between pro- and anti-apoptotic factors. Any approach 
that changes the balance in favor of apoptosis may have a therapeutic benefit. Our results 
suggest that Cx43 influences the balance between pro- and anti-apoptotic factors in the 
direction of apoptosis, possibly contributing to the improved sensitivity of cancer cells to 
CDDP. However, some studies have reported low Bcl-2 and high Bax expression in 
mesothelioma samples. A previous study helped the current understanding of apoptosis 
regulation by raising the following possibilities: one is Bax mutation, which makes it 
nonfunctional and blocks its pro-apoptotic effect (Narasimhan et al, 1998); and the other is 
breaking out of antagonists to Bax as previously suggested (Yu et al, 2008). To clarify this 
issue, a functional assay of Bax in mesothelioma cells that also compares that of Cx43-
transfectant is required. 
4.2.2.3 Interactive effect of Cx43 with Src 
Cx43 is known to interacts with the proto-oncogene product, Src. Src can directly 
phosphorylate Cx43 (Loo et al, 1995). Including mesothelioma, the Src family of nonreceptor 
tyrosine kinases are overexpressed in various human tumors, which often involves tumor 
progression and metastatic potential. In fact, a previous report revealed that total c-Src is 
highly expressed in some mesothelioma cells (Tsao et al, 2007). On the other hand, it has 
also shown that Cx43 regulates Src kinase through interaction of the Cx43 C-teminal region, 
irrespective of GJIC function (Giepmans et al, 2001).  
Src activity is regulated by tyrosine phosphorylation. Phosphorylation of Tyr416 in the 
activation loop of the kinase domain upregulates enzyme activity. We assayed for Src levels 
and activation in mesothelioma cells using antibodies which recognized total-Src and 
phospho-Src protein (an activated form, phosphorylated at Tyr416). Tyr416 antibody detects 
endogenous levels of the Src family proteins, when phosphorylated at Tyr416. As a result, 
both phospho-Src and total-Src were decreased in Cx43-transfectant, although there were no  
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Fig. 6. Downregulation of Src protein level and activity by Cx43.  
A) shows expression of total src (‘Total Src’) and phosphorelated Src (Phospho-Src, active 
form), in human mesothelioma cells, parental H28 (‘Parental’) , only mock-transfected cells 
(‘Mock+’), and Cx43-transfectant (‘Cx43+’). β-Actin was used as the internal standard. B) 
shows densitometric data for phosphorelated Src (upper) and total Src (lower). Both Toatl Src 
and Phosphorelated Src were decreased by Cx43. C) shows cell viability after CDDP treatment 
in parental mesothelioma cells detected by WST-1 assay. CDDP cytotoxic effect was enhanced 
by Src inhibitor, SU6656. ‘Control’; cells treated with only 0.1% DMSO (vehicle for CDDP), 
‘SU’; cells treated with only SU6656, ‘CDDP’; cells treated with only CDDP, and ‘SU + CDDP’; 
cells co-treated with SU6656 and CDDP. ###P < 0.001; Significant difference between ‘SU’ and 
‘SU+CDDP’, ***P <0.001; significant difference between ‘CDDP’ and ‘SU+CDDP’.  
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significant differences among cells (Figure 6A, 6B). Then, we further investigated whether 
the inhibition of Src activity affects the cytotoxicity of CDDP in mesothelioma cells by using 
a specific Src kinase inhibitor, SU6656. It was revealed that when the cells were treated with 
both CDDP and SU6656, cell viability significantly decreased as compared to that when the 
cells were treated with CDDP or SU6656 alone (Figure 6C). Our results showed that not only 
phospho-Src level but also total-Src protein level was decreased in Cx43-transfectant, 
suggesting that Cx43 somehow suppressed the Src protein expression, which in turn 
suppressed the total amount of its activation form. One report which supports our results 
showed that the effect of activated Src on survival after CDDP treatment was reversed by 
forced overexpression of Cx43 using human Cx43 cDNA transfection model (Peterson-Roth 
et al). They finally suggested that a novel application for Src kinase inhibitors in 
combination with CDDP, i.e., one of Src inhibitor, dasatinib has the potential to sensitize 
tumor cells overexpressing activated Src as well as to sensitize tumor cells without activated 
Src that are in direct contact with Src-activated cells via GJIC, and also another combination 
such as proteasome inhibitors with CDDP treatment in order to up-regulate Cx43 expression 
which sensitize to CDDP.  
Interestingly, a previous report showed that some selective inhibitors of Src kinases are 
specific inhibitors of cell cycle progression into the mid-S phase (Mizenina & Moasser, 2004), 
which corrrelates with our result of cell cycle distribution. Therefore, Cx43 may inhibit Src 
activation, which is reflected as S-phase arrest, resulting in the suppression of cell growth 
which was observed in Cx43-transfectant. Moreover, under the in vivo condition, Src 
upregulates vascular endothelial growth factor (VEGF), the most important factor in 
angiogenesis. Tumors must undergo angiogenesis for survival and for metastatic spread in a 
limited physiological environment (Folkman, 1971). Indeed, a previous report showed that a 
novel Src inhibitor, M475271, significantly inhibited VEGF-induced HUVEC proliferation, 
migration and angiogenesis (Ali et al, 2005). It is, therefore, possible that Cx43 has a more 
suppressive role in growth and metastasis in vivo, where angiogenesis always contributes to 
tumor survival. 
It has also been indicated that simultaneous inhibition of Src and its downstream factor, 
signal transducer and activator (Stat) 3, results in synergistic death of mesothelioma cells 
(Johnson et al, 2007; Tsao et al, 2007). Moreover, CDDP inactivates Stat 3 by modulating 
Janus kinase (JAK) 2 through dephosphorylation of JAK/Stat in cancer cells (Song et al, 
2004). Taken together, inhibition of Src by Cx43 and inactivation of Stat 3 by CDDP could 
induce synergistic death of mesothelioma cells. 
5. Conclusion  
From the view of previous studies including our data, we concluded that Cx43 could 
improve the chemoresistance of mesothelioma cells to CDDP mainly in a GJIC-independent 
manner (Figure 7). Also there might be another possible factors, such as hemichannel 
activity. In next step for clinical application, it should be considered that what kind of 
methodologies can be used which make possible to regulate Cx43 expression and its 
activities. There are still many concerns, however, this finding will help in overcoming 
resistance to current chemotherapy for malignant mesothelioma.  
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Fig. 7. A scheme of a new potential therapy against mesothelioma using Cx43 functions 
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